OND Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Oncopeptides AB

Watchlist Manager

Watchlist

Price: 0.1712 EUR 3.01% Market Closed

Market Cap: €36.2m

	Oncopeptides AB F:OND	SE
A	Acciona SA XMUN:AJ3	ES
	Bechtle AG OTC:BECTY	DE
	PCC Rokita SA F:229	PL
C	Computer and Technologies Holdings Ltd F:CVB	HK
I	InstallatoerGruppen A/S CSE:IG	DK
	Nfl Biosciences SAS F:82F	FR
	Tomy Co Ltd OTC:TOMYF	JP
Z	Zemaitijos Pienas AB XMUN:IU8	LT

Profitability Summary

Oncopeptides AB's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

97%

Strong 3Y Average Gross Margin

98%

Declining Gross Margin

100% > 97%

Negative Operating Margin

-243%

Negative 3Y Average Operating Margin

-685%

Operating Margin is Increasing

-1.174% > -243%

Negative Net Margin

-265%

Negative 3Y Average Net Margin

-693%

Net Margin is Increasing

-1.110% > -265%

Negative Free Cash Flow Margin

-240%

Negative 3Y Average Free Cash Flow Margin

-653%

Free Cash Flow Margin is Increasing

-1.139% > -240%

Negative ROE

-623%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-516%

ROIC is Increasing

-713% > -373%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.